Recombinant Factor XIII (Novo Nordisk)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant Factor XIII (Novo Nordisk), covering 2016-09-21 to 2016-09-21. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of a Blood Clotting Drug (Recombinant Factor XIII) Produced by Two Different Manufacturers in Healthy Male Subjects [Phase 1]